Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy
Clicks: 170
ID: 61405
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
63.8
/100
170 views
136 readers
Trending
AI Quality Assessment
Not analyzed
| Reference Key |
hemati2019developmentartificial
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hemati, M. |
| Journal | artificial cells, nanomedicine and biotechnology |
| Year | 2019 |
| DOI | 10.1080/21691401.2018.1489271 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.